The effect of lysozyme susceptibility to amyloid formation is the occurrence of a disease known as “familial or systemic amyloidosis,” characterized by the formation of lysozyme amyloid deposits in the kidneys, liver, and spleen [22]. The gene discussed is LYZ; the disease is primary systemic amyloidosis.